Results 141 to 150 of about 1,700 (296)

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Climate Information and Conflicting Goals: El Niño 1997-98 and the Peruvian Fishery

open access: yes, 1999
The development of seasonal-to-interannual climate predictions has spurred widespread claims that distributing forecasts will yield benefits for society.
Broad, Kenneth
core  

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

open access: yesMolecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis   +3 more
wiley   +1 more source

Pink salmon fishery in the European part of Russia: results for 2023

open access: yesИзвестия ТИНРО
Pink salmon is currently the main species for the anadromous fish fishery in the north of the European part of Russia. Upward trends were observed in this species returns and catches in odd years of the 2013–2021 in the regions of North-West Russia ...
I. I. Gordeev   +6 more
doaj   +1 more source

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

open access: yesMolecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi   +14 more
wiley   +1 more source

E-Governance and Management of Inland Water Ecosystems Using Time-Series Analysis of Fishery Production

open access: yes
Governance of inland water ecosystems incorporates many components, such as the policy designation for the monitoring in a systematic basis of valuable biological parameters of the ecosystem regarding planning for the collection, assembly, organization ...
Z.S. Andreopoulou, A.K. Kokkinakis
core   +1 more source

Estimating And Forecasting Pre-Fishery Abundance Of Atlantic Salmon In The North East Atlantic For The Management Of Mixed Stock Fisheries

open access: yes, 2003
No abstracts are to be cited without prior reference to the author.Most of the exploitation of Atlantic salmon takes place close to or within the rivers of origin of the stocks.
P Jan-Schon (18221260)   +2 more
core   +1 more source

MITF maintains genome stability in nonmelanocyte lineages

open access: yesMolecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir   +13 more
wiley   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy